[Treatment of parkinsonian akinesia].
D000818:Animals; D000928:Antidepressive Agents / Q000627:therapeutic use; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*; D051381:Rats; D013566:Sympathomimetics / Q000627:therapeutic use
D000928:Antidepressive Agents; D008996:Monoamine Oxidase Inhibitors; D010276:Parasympatholytics; D013566:Sympathomimetics; D004295:Dihydroxyphenylalanine
Lechenie parkinsonicheskogo akineza.